Bill Maher, Director at abrdn Life Sciences Investors (HQL), bought 1,000 shares at $13.57 ($14K) on 2023-12-28, disclosed to the SEC on 2024-01-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| AEF | BUY | 2024-08-27 | $5K | — | Filing → |
| AEF | BUY | 2024-08-16 | $5K | — | Filing → |
| JEQ | BUY | 2024-08-16 | $6K | — | Filing → |